MetLife Investment Management’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.14M | Buy |
98,158
+658
| +0.7% | +$8.21K | 0.01% | 1335 |
|
|
2025
Q4 | $1.11M | Sell |
97,500
-5,024
| -5% | -$59K | 0.01% | 1366 |
|
|
2025
Q3 | $1.3M | Sell |
102,524
-4,789
| -4% | -$69.5K | 0.01% | 1311 |
|
|
2025
Q2 | $1.7M | Sell |
107,313
-3,058
| -3% | -$45.7K | 0.01% | 1077 |
|
|
2025
Q1 | $1.65M | Sell |
110,371
-1,742
| -2% | -$30.9K | 0.01% | 1132 |
|
|
2024
Q4 | $2.13M | Buy |
112,113
+7,351
| +7% | +$155K | 0.01% | 1001 |
|
|
2024
Q3 | $2.83M | Sell |
104,762
-4,561
| -4% | -$116K | 0.02% | 831 |
|
|
2024
Q2 | $2.72M | Buy |
109,323
+59,732
| +120% | +$1.71M | 0.02% | 833 |
|
|
2024
Q1 | $1.65M | Sell |
49,591
-1,825
| -4% | -$62.4K | 0.01% | 1048 |
|
|
2023
Q4 | $1.83M | Sell |
51,416
-939
| -2% | -$29.8K | 0.01% | 980 |
|
|
2023
Q3 | $1.79M | Sell |
52,355
-1,549
| -3% | -$58.9K | 0.01% | 953 |
|
|
2023
Q2 | $2.16M | Sell |
53,904
-1,540
| -3% | -$61.2K | 0.02% | 905 |
|
|
2023
Q1 | $2.18M | Sell |
55,444
-664
| -1% | -$24.4K | 0.02% | 881 |
|
|
2022
Q4 | $1.79M | Sell |
56,108
-1,051
| -2% | -$31.7K | 0.01% | 950 |
|
|
2022
Q3 | $1.62M | Sell |
57,159
-853
| -1% | -$29.2K | 0.01% | 972 |
|
|
2022
Q2 | $2.07M | Sell |
58,012
-1,441
| -2% | -$58.3K | 0.02% | 890 |
|
|
2022
Q1 | $2.93M | Buy |
59,453
+11,156
| +23% | +$590K | 0.02% | 825 |
|
|
2021
Q4 | $2.69M | Sell |
48,297
-1,063
| -2% | -$58.5K | 0.02% | 729 |
|
|
2021
Q3 | $2.87M | Sell |
49,360
-1,255
| -2% | -$77.4K | 0.03% | 667 |
|
|
2021
Q2 | $3.2M | Sell |
50,615
-1,584
| -3% | -$104K | 0.03% | 635 |
|
|
2021
Q1 | $3.33M | Sell |
52,199
-877
| -2% | -$50.9K | 0.03% | 607 |
|
|
2020
Q4 | $2.78M | Sell |
53,076
-2,322
| -4% | -$115K | 0.03% | 664 |
|
|
2020
Q3 | $2.42M | Sell |
55,398
-1,898
| -3% | -$83.9K | 0.03% | 640 |
|
|
2020
Q2 | $2.52M | Sell |
57,296
-34
| -0.1% | -$1.44K | 0.03% | 613 |
|
|
2020
Q1 | $2.23M | Sell |
57,330
-1,754
| -3% | -$89.4K | 0.03% | 565 |
|
|
2019
Q4 | $3.34M | Sell |
59,084
-1,924
| -3% | -$107K | 0.03% | 576 |
|
|
2019
Q3 | $3.25M | Sell |
61,008
-3,485
| -5% | -$187K | 0.04% | 556 |
|
|
2019
Q2 | $3.76M | Buy |
64,493
+1,237
| +2% | +$66.5K | 0.04% | 493 |
|
|
2019
Q1 | $3.14M | Sell |
63,256
-382
| -0.6% | -$16.8K | 0.03% | 589 |
|
|
2018
Q4 | $2.37M | Sell |
63,638
-1,037
| -2% | -$37.7K | 0.03% | 682 |
|
|
2018
Q3 | $2.44M | Sell |
64,675
-2,277
| -3% | -$94.8K | 0.03% | 792 |
|
|
2018
Q2 | $2.93M | Sell |
66,952
-2,168
| -3% | -$102K | 0.03% | 625 |
|
|
2018
Q1 | $3.48M | Sell |
69,120
-1,945
| -3% | -$115K | 0.04% | 524 |
|
|
2017
Q4 | $4.68M | Buy |
+71,065
| New | +$4.52M | 0.05% | 367 |
|
Other funds holding XRAY
VPM
SCA
VCM
CB
AI
MetLife Investment Management's XRAY Position: Q1 2026 in Review
MetLife Investment Management increased its Dentsply Sirona (XRAY) stake by 0.67% in Q1 2026, buying an estimated $8.21K and bringing the position to 98,158 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1335.
MetLife Investment Management first reported a position in XRAY in Q4 2017 and has held it in 34 quarters since. The position peaked at $4.68M in Q4 2017. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.
- MetLife Investment Management held 98,158 shares of Dentsply Sirona worth $1.14M as of Q1 2026.
- MetLife Investment Management bought 658 Dentsply Sirona shares in Q1 2026, an estimated $8.21K.
- Dentsply Sirona made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1335 holding.
- MetLife Investment Management first reported a position in Dentsply Sirona in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Dentsply Sirona position peaked at $4.68M in Q4 2017.
- 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.